Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Community portal
Project chat
Create a new Item
Recent changes
Random Item
Query Service
Nearby
Help
Special pages
Lexicographical data
Create a new Lexeme
Recent changes
Random Lexeme
Search
Search
English
Appearance
Donate
Create account
Log in
Personal tools
Donate
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
reslizumab
(Q7315650)
Item
Discussion
English
Read
View history
Tools
Tools
move to sidebar
hide
Actions
Read
View history
General
What links here
Related changes
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Concept URI
Print/export
Create a book
Download as PDF
Printable version
In other projects
Appearance
move to sidebar
hide
From Wikidata
pharmaceutical drug
Cinqair
Sch 55700
DCP 835
edit
Language
Label
Description
Also known as
default for all languages
No label defined
–
English
reslizumab
pharmaceutical drug
Cinqair
Sch 55700
DCP 835
Statements
instance of
type of chemical entity
0 references
subclass of
chemical compound
0 references
has use
medication
0 references
defined daily dose
7.1
milligram
route of administration
parenteral route of administration
1 reference
reference URL
https://www.whocc.no/atc_ddd_index/?code=R03DX08
active ingredient in
Cinqaero
1 reference
European Medicines Agency product number
EMEA/H/C/003912
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003912/human_med_002012.jsp
retrieved
22 March 2017
World Health Organisation international non-proprietary name
reslizumab
(English)
0 references
legal status (medicine)
boxed warning
1 reference
reference URL
https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
title
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.
(English)
LiverTox likelihood score
LiverTox toxicity likelihood category E
1 reference
stated in
LiverTox
retrieved
8 April 2021
reference URL
https://www.ncbi.nlm.nih.gov/books/n/livertox/Reslizumab
last update
14 March 2017
subject has role
antiasthmatic
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
C515492
retrieved
15 March 2018
monoclonal antibody
0 references
Identifiers
CAS Registry Number
241473-69-8
0 references
ChEMBL ID
CHEMBL2107884
0 references
LiverTox ID
Reslizumab
0 references
ATC code
R03DX08
0 references
World Health Organisation international non-proprietary name numeric ID
8106
0 references
Guide to Pharmacology Ligand ID
8091
0 references
MeSH descriptor ID
C515492
0 references
RxNorm ID
1746889
0 references
DrugBank ID
DB06602
0 references
UNII
35A26E427H
0 references
MedlinePlus drug identifier
a616023
0 references
PatientsLikeMe treatment ID
reslizumab
0 references
NDF-RT ID
N0000192520
0 references
Freebase ID
/m/027yyxw
0 references
Microsoft Academic ID
2779226105
0 references
WikiProjectMed ID
Reslizumab
0 references
YSO ID
39038
1 reference
stated in
YSO-Wikidata mapping project
retrieved
24 March 2023
Sitelinks
Wikipedia
(11 entries)
edit
dewiki
Reslizumab
enwiki
Reslizumab
eswiki
Reslizumab
frwiki
Reslizumab
itwiki
Reslizumab
orwiki
ରେସଲିଜୁମାବ
plwiki
Reslizumab
ptwiki
Reslizumab
ruwiki
Реслизумаб
tewiki
రెస్లిజుమాబ్
viwiki
Reslizumab
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
Retrieved from "
https://www.wikidata.org/w/index.php?title=Q7315650&oldid=2254409912
"
Search
Search
reslizumab
(Q7315650)
Add topic
[8]
ページ先頭
©2009-2025
Movatter.jp